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Abstract: The effect of insertion of lactic acid (Lac) residues into peptide helices has been probed
using specifically designed sequences. The crystal structures of 11-residue and 14-residue dep-
sipeptides Boc–Val–Val–Ala–Leu–Val–Lac–Leu–Aib–Val–Ala–Leu–OMe (1) and Boc–Val–Ala–
Leu–Aib–Val–Ala–Leu–Val–Lac–Leu–Aib–Val–Ala–Leu–OMe (3), containing centrally positioned
Lac residues, have been determined. The structure of an 11-residue peptide Boc–Val–Ala–Leu–
Aib–Val–Ala–Leu–Aib–Val–Ala–Leu–OMe (2), analog of a which is an amide previously deter-
mined Lac-containing depsipeptide, Boc–Val–Ala–Leu–Aib–Val–Lac–Leu–Aib–Val–Ala–Leu–OMe
I. L. Karle, C. Das, and P. Balaram, Biopolymers, Vol. 59, (2001) pp. 276–289], is also reported.
Peptide 1 adopts a helical fold, which is stabilized by mixture of 431 and 531 hydrogen bonds.
Peptide 2 adopts a completely -helical conformation stabilized by eight successive 531 hydrogen
bonds. Peptide 3 appears to be predominately -helical, with seven 531 hydrogen bonds and three
431 interaction interspersed in the sequence. In the structure of peptide 3 in addition to water
molecules in the head-to-tail region, hydration at an internal segment of the helix is also observed.
A comparison of five related peptide helices, containing a single Lac residue, reveals that the
hydroxy acid can be comfortably accommodated at interior positions in the helix, with the closest
C¢O. . .O distances lying between 2.8 and 3.3 A˚ . © 2002 Wiley Periodicals, Inc. Biopolymers 64:
255–267, 2002
Keywords: 431/531 hydrogen bonds; depsipeptides; -helix; lactic acid; x-ray crystal
structures
INTRODUCTION
The insertion of -hydroxy acids into peptide se-
quences provides a method for evaluating the impor-
tance of specific hydrogen bonds in the stabilization
of peptide secondary structures. The field of polypep-
tide stereochemistry has long been influenced by
Pauling’s successes in formulating -helices and
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-sheets as stable conformations for polypeptides, an
insight driven largely by the recognition that cooper-
ative hydrogen bond formation between backbone CO
and NH groups is the critical element in determining
the folded structures.1,2 How much do hydrogen
bonds really contribute to the stability of the helical
polypeptide structure? In the case of apolar peptides
the implicit assumption is made that hydrogen bonds
significantly stabilize peptide helices in poorly solvat-
ing media. As a part of a program to investigate the
effect of hydrogen-bond deletion on the structure of
well-characterized helical sequences, we have em-
barked on a systematic study of the structural charac-
teristics of linear peptides containing a single substi-
tution of lactic acid (Lac) for alanine (Ala) in de-
signed peptide helices. We have previously described
structures of three lactic acid containing depsipeptides
of length 10, 11, and 14 residues.3 Ohyama and co-
workers have recently described the crystal structure
of two depsipeptides each containing three Lac resi-
dues, of length 11 and 15 residues.4,5 In this report, we
describe the crystal structure of 11 and 14 residue
peptides, containing a centrally positioned Lac resi-
due and also the structure of an all amide analog of
peptide. Structures are reported for the following se-
quences:
Boc–Val–Val–Ala–Leu–Val–Lac–Leu–Aib–Val–
Ala–Leu–OMe (1)
Boc–Val–Ala–Leu–Aib–Val–Ala–Leu–Aib–Val–
Ala–Leu–OMe (2)
Table I Crystal and Diffraction Parameters for Peptides 1–3
Peptide 1 Peptide 2 Peptide 3
Empirical formula C57 H102 N10O15  H2O C56 H101 N11O14  3H2O C70 H125 N13O18  2H2O
Crystal habit Clear rectangular shaped Clear rectangular shaped Clear
Crystal size (mm) 0.3  0.2  0.15 0.4  0.23  0.075 0.25  0.2  0.075
Crystallizing solvent Acetonitrile/water Isoproponal/water Isoproponal/water
Space group P212121 P21 P21
Cell parameters
a (A˚ ) 9.893(3) 9.938(3) 9.814(2)
b (A˚ ) 20.7694(11) 34.342(3) 19.953(5)
c (A˚ ) 33.839(5) 10.434(2) 22.018(2)
 (deg) 90.00(1) 90.00 90.00
 (deg) 90.01(2) 93.99(2) 93.89(2)
 (deg) 90.05(2) 90.00 90.00
Volume (A˚ 3) 6952.8(24) 3552.3(13) 4301.7(13)
Z 4 2 2
Molecules/asym unit 1 1 1
Cocrystallized solvent One water molecule Three water molecule Two water molecule
Molecular weight 1185.50 1206.53 1472.86
Density (g/cm3) (cal) 1.133 1.128 1.137
F (000) 2576 1312 1600
Radiation CuK CuK CuK
(  1.5418 A˚ ) (  1.5418 A˚ ) (  1.5418 A˚ )
Temperature (°C) 21 21 21
2 Range (°) 136 130 130
Scan type -2 -2 -2
Scan speed Variable Variable Variable
Independent reflection 6892 6159 7540
Observed reflection 5309 5158 3688
[F  4(F)]
Final R (%) 6.15 4.3 10.3
Final wR2 (%) 16.46 11.19 27.87
Goodness-of-fit (S) 1.05 1.07 1.11
max (e A˚ 3) 0.46 0.23 0.43
min (e A˚ 3) 0.35 0.16 0.57
Data-to-parameter ratio 7:1 6.8:1 3.9:1
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Boc–Val–Ala–Leu–Aib–Val–Ala–Leu–Val–Lac–
Leu–Aib–Val–Ala–Leu–OMe (3)
A comparison with the other reported depsipeptide
helices is presented. The results suggest that the re-
placement of an amide NH group by an ester oxygen
atom in the center of the peptide helix can be tolerated
with the minor adjustment of the 310/-helical hydro-
gen bond pattern near the site of replacement.
EXPERIMENTAL PROCEDURE
Peptides 1–3 were synthesized by conventional solution phase
methods by using a fragment condensation strategy. The t-
butyloxycarbonyl (Boc) group was used for N-terminal pro-
tection and the C-terminus was protected as a methyl ester.
Deprotections were performed using 98% formic acid or sa-
ponification for N- and C-terminus, respectively. Couplings
were mediated by dicyclohexylcarbodiimide/1-hydroxybenzo-
triazole (DCC/HOBt), and in case of coupling involving the
hydroxy group of lactic acid (for ester formation), DCC and
dimethylaminopyridine (DMAP) were employed.3 The final
peptides were purified by reverse phase, medium pressure
chromatography (MPLC) (C18, 40–60 	) and by high perfor-
mance liquid chromatography (HPLC) on a reverse phase C18
column (5–10 	, 7.8  250 mm) using methanol–water gra-
dients. The purified peptides were characterized by electros-
pray mass spectrometry on a Hewlett-Packard HP-1100 LC-
MSD mass spectrometer and were fully characterized by 500
MHz 1H NMR.
X-ray Diffraction
Crystals of peptides 1–3 were grown by slow evap-
oration of the solutions of the peptides in acetoni-
FIGURE 1 Molecular conformation of peptide 1 (a) and 2 (b) in crystals. Hydrogen bonds are
shown by dotted lines.
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Table II Torsion Anglesa of Peptide 1
Residues 
 (deg)  (deg)  (deg) 1 (deg) 2 (deg)
Val (1) 61.5b 21.1 174.5 56.6,74.4
Val (2) 53.3 32.3 179.7 75.1, 154.6
Ala (3) 64.2 18.7 175.8
Leu (4) 70.2 23.6 177.5 64.6 72.3, 165.5
Val (5) 75.0 34.8 173.4 51.6,177.3
Lac (6) 66.6 40.9 176.8
Leu (7) 60.9 41.4 173.5 176.4 57.2,177.1
Aib (8) 52.6 40.3 175.4
Val (9) 58.9 26.9 178.9 67.3, 164.9
Ala (10) 80.1 12.9 173.4
Leu (11) 111.6 20.5c 178.6d 55.2 57.1,178.9
a Lac: lactic acid. The torsion angles for rotation about bonds of the peptide backbone (
, , and ) and about bonds of the amino acid
side chains (1, 2) as suggested by the IUPAC-IUB Commission on Biochemical Nomenclature. Biochemistry, 1970, Vol. 9, pp. 3471–3479.
b C(0)—N(1)–C(1)—C(1).
c N(10)—C(10)—C(10)—OMe.
d C(10)—C(10)—O(OMe)—C(OMe).
Table III Hydrogen-Bond Parameters of Peptide 1 (Boc–Val–Val–Ala–Leu–Val–Lac–Leu–Aib–Val–Ala–Leu–OMe)
Type Donor Acceptor
N. . .O
(Å)
H. . .O
(Å)
CAO. . .H
(deg)
CAO. . .N
(deg)
O. . .HN
(deg)
Intermolecular
c N(1)a O(10) 2.955 2.188 117.2 126.0 148.4
c N(2)a O1W 3.286 2.434 167.5
c O1W O11b 2.942
Intramolecular
431c N(3) O(0) 2.959 2.143 134.0 137.2 158.4
431c N(4) O(1) 2.896 2.099 118.6 125.5 153.9
431c N(5) O(2) 3.040 2.259 115.1 122.0 150.9
431 N(7) O(4) 3.430 3.065 77.1 90.2 108.0
431 N(8) O(5) 3.339 2.841 85.4 98.1 118.6
431 N(9) O(6) 3.420 2.740 105.0 113.2 136.9
431c N(10) O(7) 2.929 2.158 122.8 130.4 149.1
431c N(11) O(8) 3.017 2.183 115.9 120.5 163.3
531 N(4) O(0) 4.441 3.803 128.6 136.4 133.7
531 N(5) O(1) 4.075 3.409 140.6 148.8 136.4
531c N(7) O(3) 3.035 2.215 142.0 147.4 159.5
531c N(8) O(4) 2.909 2.171 131.4 140.3 143.8
531 N(9) O(5) 3.576 2.812 141.1 144.8 148.8
531 N(10) O(6) 4.192 3.491 135.7 142.6 140.7
531 N(11) O(7) 3.816 3.305 140.6 151.2 120.7
Solventc O1W O(9) 2.885
a Symmetrically related by x, y  1, z.
b Symmetrically related by x  1, y, z.
c These are acceptable hydrogen bonds.
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trile/water (for peptide 1), and isoproponal/water
(for peptides 2 and 3), respectively. X-ray diffrac-
tion data for the peptide crystals were collected at
room temperature, 21°C, on an automated four-
circle diffractometer with CuK (  1.5418 A˚ )
radiation. Unit cell parameters were obtained and
refined by least-squares fit of the angular setting of
25 accurately determined reflections in the range 0°
   25°. Intensity data were collected up to 2
 136° for peptide 1 and 130° for peptides 2 and 3
using - 2 scans, with variable speed. Diffraction
quality was much poorer for 3 as compared to 1 and
2. Two reflections used as standards, monitored
every hour, remain constant within 3%. Lorentz,
polarization, and absorption corrections were applied (	
 0.68 mm1 for peptide 1, 	 0.63 mm1 for peptide
2, and 	  0.68 mm1 for peptide 3).
Structure Solution and Refinement
The structures of peptides 1 and 2 were determined by
direct phase determination method using SHELXS-
97.6 For peptide 3, we used the Shake-and-Bake
method, which uses Minimal-Function Phase Refine-
ment and Fourier filtering procedure.7 This gave a
fragment containing 81 atoms. Remaining atoms were
located from difference Fourier maps. Refinement for
all the three structures were carried out with a full
matrix anisotropic least-squares method using
SHELXL-97.8 The hydrogen atoms were fixed geo-
metrically in the idealized position, and refined as
riding over the heavier atom to which they were
bonded. The final R factor was 6.15% (wR2
 16.46%) for peptide 1, 4.3% (wR2  11.19%) for
peptide 2, and 10.34% (wR2  27.87%) for peptide 3.
All the relevant crystallographic data collection pa-
FIGURE 2 Packing of the molecules in peptide 1 (a), and 2 (b). The arrows indicate the direction
of helix axes and mode of aggregation.
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rameters and structure refinement details for the three
peptides are summarized in Table I.
RESULTS
Structure of Peptide 1 (Boc–Val–Val–Ala–
Leu–Val–Lac–Leu–Aib–Val–Ala–Leu–OMe)
Figure 1a shows a view of the molecular conforma-
tion in crystals. The relevant backbone and side-chain
torsion angles are listed in Table II and hydrogen-
bond parameters in Table III. In view of the extended
discussion in the literature on 310- and -helices in
peptides,9–13 we have provided the parameters for
both 431 and 531 interactions in the cases of all the
molecules reported, to facilitate the choice between
various hydrogen-bonding possibilities.14–19 Inspec-
tion of the potential hydrogen-bonding pattern in Ta-
ble III suggests that residues 1–4 form a 310-helical
segment, stabilized by three successive 431 hydro-
gen bonds. The segment spanning residues 5–7 is
better described as a part of an -helical turn, with
two successive 531 hydrogen bonds [N(7). . .O(3)
and N(8). . .O(4)]. The polypeptide chain tightens
again to a 310-helical segment for residues 8–10, with
two successive 431 hydrogen bonds [N(10). . .O(7)
and N(11). . .O(8)].
The aggregation of helices into infinite columns is
unexceptional with molecules in a column stabilized
by head-to-tail hydrogen bonding, between exposed
NH and CO groups.19–21 There is a lone water mol-
ecule providing an additional intermolecular hydro-
gen bond. Within the crystal helical columns run
parallel and antiparallel in pairs (_+_) as indicated
by the arrows in the Figure 2a. Figure 3a provides a
view of the environment of the water molecule.
Structure of Peptide 2
(Boc–Val–Ala–Leu–Aib–Val–Ala–Leu–Aib–
Val–Ala–Leu–OMe)
A view of the molecular conformation in crystals is
shown in Figure 1b. The relevant torsion angles and
potential hydrogen-bond parameters are listed in Ta-
bles IV and V, respectively. The peptide backbone
adopts an almost perfect -helical conformation with
eight successive 531 hydrogen bonds (Table V). The
helices in crystals are packed in parallel fashion as
indicated by arrows in Figure 2b, with as many as
three water molecules entrapped. Figure 3b shows a
view of the intermolecular hydrogen-bond network
mediated by water molecules.
Structure of Peptide 3
(Boc–Val–Ala–Leu–Aib–Val–Ala–Leu–Val–
Lac–Leu–Aib–Val–Ala–Leu–OMe)
Figure 4a shows the molecular conformation of the
peptide in crystals. The relevant torsion angles and
potential hydrogen bond parameters are listed in Ta-
bles VI and VII, respectively. The structure appears to
be predominately -helical, with seven 531 hydro-
FIGURE 3 Environment of water molecules in peptide 1 (a) and 2 (b). The intermolecular
hydrogen bonds are shown in dotted lines.
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Table IV Torsion Anglesa of peptide 2
Residues 
 (deg)  (deg)  (deg) 1 (deg) 2 (deg)
Val (1) 63.2b 53.4 173.8 65.9, 170.0
Ala (2) 64.3 43.1 179.6
Leu (3) 68.2 40.7 176.2 178.4 60,177.1
Aib (4) 51.8 51.5 176.9
Val (5) 64.5 46.6 179.2 68.1, 167.4
Ala (6) 55.5 46.4 179.1
Leu (7) 67.2 47.9 174.1 70.0 70, 168.1
Aib (8) 59.8 34.0 176.0
Val (9) 92.0 42.7 178.2 52.4,175.2
Ala (10) 71.0 37.7 173.6
Leu (11) 80.3 47.2c 176.9d 64.0 66.3, 170.6
a As in Table II.
b C(0)—N(1)—C(1)—C(1).
c N(10)—C(10)—C(10)—OMe.
d C(10)—C(10)—O(OMe)—C(OMe).
Table V Hydrogen-Bond Parameters of Peptide 2 (Boc–Val–Ala–Leu–Aib–Val–Ala–Leu–Aib–Val–Ala–Leu–OMe)
Type Donor Acceptor
N. . .O
(A˚ )
H. . .O
(A˚ )
CAO. . .H
(deg)
CAO. . .N
(deg)
O. . .HN
(deg)
Intermolecular
d N(1)a O1W 2.991 2.143 169.3
d N(2)b O3W 2.908 2.071 164.7
d N(3)b O2W 3.010 2.192 159.1
d O1W O(10)c 2.804
d O3Wc O1W 2.920
Intramolecular
431 N(3) O(0) 3.601 3.210 98.4 110.4 110.4
431 N(4) O(1) 3.384 3.029 92.9 106.3 107.2
431 N(5) O(2) 3.361 2.947 92.2 104.8 111.7
431 N(6) O(3) 3.253 2.907 90.6 104.7 106.2
431 N(7) O(4) 3.492 3.050 92.7 104.4 114.2
431 N(8) O(5) 3.313 2.945 93.2 106.9 108.0
431 N(9) O(6) 3.635 3.015 92.4 102.1 130.7
431 N(10) O(7) 3.543 3.191 91.0 103.9 107.3
431 N(11) O(8) 4.583 4.193 68.4 78.0 111.8
531d N(4) O(0) 2.971 2.146 154.8 160.2 160.8
531d N(5) O(1) 3.058 2.217 153.4 157.0 166.0
531d N(6) O(2) 2.900 2.060 151.5 155.8 165.1
531d N(7) O(3) 2.989 2.138 156.7 158.6 170.1
531d N(8) O(4) 3.012 2.177 150.1 154.8 163.5
531d N(9) O(5) 3.046 2.260 153.8 158.5 152.0
531d N(10) O(6) 2.960 2.141 145.9 151.9 159.0
531d N(11) O(7) 2.943 2.134 143.0 149.8 156.0
Solventd O1W O(8) 2.775
Solventd O2W O(9) 2.872
Solventd O3W O(11) 2.842
a Symmetrically related by x  2, y  1
2
, z.
b Symmetrically related by x  2, y  1
2
, z  1.
c Symmetrically related by x, y, z  1.
d Acceptable hydrogen bonds.
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FIGURE 4 (a) Molecular conformation of peptide 3. (b) Packing of the molecule arrows
indicating the direction of helix axes and mode of aggregation.
Table VI Torsion Anglesa of Peptide 3
Residue 
 (deg)  (deg)  (deg) 1 (deg) 2 (deg)
Val(1) 57.2b 32.4 178.4 73.6,161.5
Ala(2) 61.5 38.4 177.8
Leu(3) 65.0 45.1 179.5 179.8 62.5,175.3
Aib(4) 55.1 41.9 177.4
Val(5) 70.7 42.7 179.9 170.4,66.6
Ala(6) 65.3 23.5 177.5
Leu(7) 65.4 35.0 178.9 172.7 65.3,170.3
Val(8) 61.8 43.6 178.4 54.0,178.6
Lac(9) 68.2 37.6 175.6
Leu(10) 59.0 43.9 168.0 176.3 64.4,170.2
Aib(11) 61.1 38.1 175.9
Val(12) 81.3 4.7 172.5 68.8,55.4
Ala(13) 93.9 16.6 177.4
Leu(14) 89.5 168.4c 172.8d 64.3 52.1, 175.2
a As in Table II.
b C(0)—N(1)—C(1)—C(1).
c N(14)—C(14)—C(14)—O(OMe).
d C(14)—C(14)—O(OMe)—C(OMe).
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gen bonds (Table VII). Three 431 interaction are
interspersed in the sequence. The 431 hydrogen
bonds N(3). . .O(0) and N(13). . .O(10) lie at the N-
and C-termini of the helix. The observation of a single
310-helical turn at helix termini is fairly common in
proteins and peptides.22,23 Interestingly, a single 431
hydrogen bond N(8). . .O(5) is observed at the center
of the helix. The placement of the Lac residue at
position 9 precludes formation of an N(9). . .O(5)
interaction. The molecules are packed together in
crystals with adjacent helical columns running anti-
parallel in pairs as indicated by arrows in Figure 4b.
Three water sites are observed in crystals in the in-
terhelical space between the head and tail regions of
the adjacent helical column. There are two water sites
O1w and O2w, both of which show half occupancy.
The proximity of the sites precludes the simultaneous
occupation of both positions. Interestingly, a water
molecule (O3w) is observed in the space between the
adjacent columns, which forms a hydrogen bonded
Table VII Hydrogen-Bond Parameters of Peptide 3 (Boc–Val–Ala–Leu–Aib–Val–Ala–Leu–Val–Lac–
Leu–Aib–Val–Ala–Leu–OMe)
Type Donor Acceptor
N. . .O
(A˚ )
H. . .O
(A˚ )
CAO. . .H
(deg)
CAO. . .N
(deg)
O. . .H—N
(deg)
Intermolecular
d N(1) O(13)a 2.946 2.093 127.7 130.3 170.98
d N(2) O2Wb,e 3.029 2.410 129.23
d O1We O(11)b 2.952
d O1We O(13)a 2.810
d O3Wc O(6) 3.071
Intramolecular
431d N(3) O(0) 3.176 2.573 110.0 119.3 128.0
431 N(4) O(1) 3.257 2.865 87.4 101.2 109.7
431 N(5) O(2) 3.469 2.948 86.3 97.3 120.9
431 N(6) O(3) 3.081 2.675 97.6 112.1 110.3
431 N(7) O(4) 3.554 2.915 89.9 100.0 132.6
431d N(8) O(5) 3.099 2.391 111.4 120.1 139.9
431 N(10) O(7) 3.309 2.938 80.5 94.0 108.1
431 N(11) O(8) 3.251 2.695 88.8 101.1 123.7
431 N(12) O(9) 3.451 2.834 99.5 108.8 130.1
431d N(13) O(10) 2.904 2.145 108.1 117.4 147.0
431 N(14) O(11) 3.482 2.683 100.3 106.0 155.3
531d N(4) O(0) 3.433 2.604 144.1 148.4 162.2
531d N(5) O(1) 3.110 2.297 148.3 152.4 157.5
531d N(6) O(2) 3.086 2.270 138.4 144.1 158.5
531d N(7) O(3) 2.969 2.226 156.9 164.8 144.5
531d N(8) O(4) 3.879 3.166 132.4 138.6 141.8
531d N(10) O(6) 3.036 2.213 145.5 150.9 160.1
531d N(11) O(7) 2.889 2.157 136.5 145.3 142.8
531d N(12) O(8) 3.432 2.644 144.7 148.6 152.9
531 N(13) O(9) 3.552 2.975 134.9 146.0 126.3
531 N(14) O(10) 3.327 2.741 153.0 164.5 126.6
Solventd N(2) O1We 2.917 2.062 172.1
Solventd O2We O(11) 2.869
Solventd O2We O(14) 2.992
Solventd O3W O(4) 2.861
a Symmetrically related by (x1, y, z1).
b Symmetrically related by (x, y, z1).
c Symmetrically related by (x1, y, z).
d Acceptable hydrogen bonds.
e The occupancy of O1W  O2W  0.5.
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link between O(6) of Ala(6) CO and O(4) of
Aib(4)CO of symmetry-related molecules. The en-
trapment of water in the hydrophobic spaces between
adjacent helical columns is a relatively rare occur-
rence.24–27 The presence of a Lac residue at position
9 presumably results in perturbation of hydrogen-
bond patterns facilitating backbone hydration in the
middle of the helix. Figure 5 shows the water-medi-
ated intermolecular hydrogen-bonding patterns.
DISCUSSION
The determination of the crystal structures of peptides
1–3 provides an opportunity for comparing the effect
of Lac residue incorporation into peptide helices and
the effect of positioning of the residue along the
sequence. A comparison of these structures with the
structures of three lactic acid containing helices 4–6
reported earlier3 is presented below. For the purpose
of the present analysis, the peptides may be divided
into two groups.
Boc–Val–Val–Ala–Leu–Val–Lac–Leu–Aib–Val–
Ala–Leu–OMe (peptide 1)
Boc–Val–Ala–Leu–Aib–Val–Lac–Leu–Aib–Val–
Leu–OMe (peptide 4)
Boc–Val–Ala–Leu–Aib–Val–Lac–Leu–Aib–Val–
Ala–Leu–OMe (peptide 5)
Boc–Val–Ala–Leu–Aib–Val–Ala–Leu–Aib–Val–
Ala–Leu–OMe (peptide 2)
and
Boc–Val–Ala–Leu–Aib–Val–Ala–Leu–Val–Lac–
Leu–Aib–Val–Ala–Leu–OMe (peptide 3)
Boc–Val–Ala–Leu–Aib–Val–Ala–Leu–Val–Ala–
Leu–Aib–Val–Lac–Leu–OMe (peptide 6)
FIGURE 5 Environment of water molecules in peptide 3. The intermolecular hydrogen bonds are
shown in dotted lines. (Asterisk indicates the occupancy of O1w and O2w  0.5.)
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In the first group all the four peptides are 10–11
residues in length with peptides 1, 4, and 5 containing
lactic acid at position 6. Peptide 2 is the analog of
peptide 5 in which the Lac(6) residue is replaced by
an Ala residue (Peptide 2 is the amide analog of
depsipeptide 5). The two 14-residue peptides 3 and 6
differ only in the position of Lac residue. In peptide 3
the Lac residue is at position 9 in the potential helical
segment. In peptide 6 the Lac residue is at position 13,
the C-terminus of the helix.
Effect of Lac Residues in the Center of
Helical Segments
Peptide 1 and 3–5 provide examples of Lac residues
accommodated comfortably into the helical peptide
segment, without major distortion. Figure 6 illustrates
the environment of the Lac residue in five examples
where it is located in the interior of the helix (note in
peptide 5 there are two independent molecules in the
asymmetric unit). For comparison, a corresponding
environment of Ala(6) in the all-amide analog is also
shown. In the helical peptide 2 (all-amide analog), the
N(6). . .O(3),N(7). . .O(3) distances are 3.2 and 2.9 A˚ ,
respectively. It is observed that in all the five cases
where the Lac residue is inserted the corresponding
O(3). . .O(6)Lac, distances are between 3.1 and 3.3 A˚
[note in peptide 3 the Lac residue is at position 9 and
the relevant distance is O(6). . .O(9)Lac]. The
N(7). . .O(3) distance [N(10). . .O(6) in peptide 3] lies
between 2.9 and 3.1 A˚ .
Thus, there is very little difference locally at the
site of lactic acid insertion with the oxygen atom of
the hydroxy acid comfortably accommodated in place
of the NH group within the body of peptide helix.
Similar observations have been made in the case of
two depsipeptides [Boc–(Leu–Leu–Lac)3–Leu–Leu–
OEt5 and Boc–(Leu–Leu–Ala)2–(Leu–Leu–Lac)3–
OEt4] in which the former contains three lactic acid
and the later contains two lactic acid residues. The
FIGURE 6 Environment of the Lac(6), ester oxygen atom O(6) in peptides 1, 3, 4, and 5 (A, B)
compared with the surroundings of the Ala(6) NH group in peptide 2.
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reported C¢O. . .O distances in the 11-residue peptide
are 3.47 and 3.24 A˚ , while in the 15-residue peptide
the corresponding distances are 3.81 and 3.87 A˚ . It is
noteworthy that in both peptides containing multiple
Lac residues the reported O. . .O distances are signif-
icantly greater although the overall helical fold is not
perturbed.
The most significant effect of lactic acid insertion
appear to be a readjustment in the 310/-helical hy-
drogen-bonding patterns found in helical peptides. In
retrospect, it is not surprising that peptide helices are
able to accommodate the loss of a potential hydrogen
bond by minor readjustment to allow a transition
between 531 and 431 interactions, and also by
bifurcation of hydrogen-bond interactions.
A comparison of the 14-residue peptides 3 and 6
(Figure 7) suggests that the Lac positioning may be used
to facilitate helix termination in designed sequences.
While Lac(9) is comfortably accommodated into a he-
lical segment in peptide 3, Lac(13) in peptide 6 lies
outside the helix. Notably, in the structure of peptide 6
there is an achiral Aib residue located at position 11. The
loss of the hydrogen-bonding NH group at position 13 in
a potentially continuous helix appears to be sufficient to
induce the energetically accessible left-handed helical
conformation (L) at Aib11. This in turn provides helix
termination in a Schellman motif stabilized by a strong
631 hydrogen bond.
CONCLUSIONS
The structure determination of two peptide helices
containing a single internal Lac residue and the all-
FIGURE 7 Superposition of peptides 3 and 6 to emphasize the difference in conformation arising
due to helix termination by a Schellman motif in peptide 6.
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amide analog of a previously determined depsipeptide
has provided an opportunity to examine the structural
consequences of replacing an NH group by an oxygen
atom in helical peptides. The substitution of an
-amino acid by a -hydroxy acid is isosteric. The
observation of helical peptide folds accommodating
Lac residues in internal positions of a helix in as many
as six independent structures, including two deter-
mined in the present study, suggests that deletion of a
single hydrogen bond can be easily compensated by
readjustments of the backbone, resulting in local tran-
sition between 431 and 531 interactions. The short
C¢O. . .O distances of 2.8–3.3 A˚ observed in all cases
of single lactic acid containing peptides suggests that
proximity between two oxygen atoms is not a major
destabilizing factor. The example of the 14 residue
peptides 3 and 6, suggests that the placement of lactic
acid at the C-terminal end of the helices may provide
a signal for termination, particularly an achiral residue
capable of adopting left-handed -helical conforma-
tion is positioned two residue ahead of Lac residue.
Indeed, a similar pattern has been observed for the
hydrogen-bond interrupting Pro residue in proteins,
where the actual site of helix termination occurs at
two residues preceding proline.28 Interestingly, the
comparison of depsipeptide 5 and its all-amide analog
peptide 2 reveals that the oxygen atom of the Lac(6)
hydroxyl group in 5 sits snugly in a position similar to
that of the corresponding NH group in peptide 2.
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